Glucose Health Inc Financials

GLUC

Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2017 Currency USD FYE December

This page shows Glucose Health Inc (GLUC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GLUC FY2016 2026-04-22

Glucose Health’s 2016 sales jump still sat inside a debt-heavy structure where interest burden overwhelmed operating progress.

Sales jumped from $4K in FY2015 to $313K in FY2016, yet operating cash flow remained -$39K, so the business showed first signs of commercial traction without becoming self-funding. More telling, interest expense of $324K was far above gross profit of $19K, which places the main economic strain in the capital structure rather than in production alone.

With $21K of cash against $529K of current liabilities, liquidity was extremely tight; day-to-day survival depended more on financing than on customer cash receipts. The $58K financing inflow more than covered the -$39K operating outflow, showing how the business was still being bridged externally.

The company moved from a below-cost sales profile in FY2013-FY2014 to a positive gross margin by FY2015-FY2016, so the product economics improved before the balance sheet did. But FY2016 gross margin was only 6.1%, leaving very little room for overhead and financing costs to be absorbed by the underlying business.

Financial Health Signals

Financial health score pending refresh

We are recalculating Glucose Health Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-269.78

Glucose Health Inc scores -269.78, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($9.9M) relative to total liabilities ($529K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/7

Glucose Health Inc passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.10x

For every $1 of reported earnings, Glucose Health Inc generates $0.10 in operating cash flow (-$39K OCF vs -$410K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-0.3x

Glucose Health Inc earns $-0.3 in operating income for every $1 of interest expense (-$87K vs $324K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$313K

YoY+7232.1%

Glucose Health Inc generated $313K in revenue in fiscal year 2016. This represents an increase of 7232.1% from the prior year.

EBITDA

N/A

Net Income

-$410K

Glucose Health Inc reported -$410K in net income in fiscal year 2016.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$21K

YoY+899.6%

5Y CAGR+201.8%

Glucose Health Inc held $21K in cash against $0 in long-term debt as of fiscal year 2016.

Dividends Per Share

N/A

Shares Outstanding

YoY+50.5%

Glucose Health Inc had 3M shares outstanding in fiscal year 2016. This represents an increase of 50.5% from the prior year.

Margins & Returns

Gross Margin

6.1%

YoY-3.2pp

Glucose Health Inc's gross margin was 6.1% in fiscal year 2016, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the prior year.

Operating Margin

-27.7%

Glucose Health Inc's operating margin was -27.7% in fiscal year 2016, reflecting core business profitability.

Net Margin

-131.0%

Glucose Health Inc's net profit margin was -131.0% in fiscal year 2016, showing the share of revenue converted to profit.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GLUC Income Statement

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$313K+7232.1%	$4K+56.0%	$3K+1122.8%	$224	N/A	N/A
Cost of Revenue	$294K+7488.7%	$4K-83.5%	$23K+913.6%	$2K	N/A	N/A
Gross Profit	$19K+4728.0%	$397+101.9%	-$21K-891.2%	-$2K	N/A	N/A
R&D Expenses	N/A	$48-98.8%	$4K	N/A	N/A	N/A
SG&A Expenses	$52K	N/A	$16K-58.7%	$39K+584.9%	$6K-60.7%	$15K
Operating Income	-$87K	N/A	N/A	N/A	-$361K+59.3%	-$889K
Interest Expense	$324K	N/A	$110K	N/A	$38K+263.0%	$10K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$410K	N/A	N/A	N/A	-$399K+55.6%	-$899K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'17	Q2'17	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15
Revenue	$24K-30.1%	$34K+125.3%	$15K-0.5%	$15K+619.9%	$2K-99.3%	$296K+246407.5%	$120-92.7%	$2K
Cost of Revenue	$790+190.4%	$272-98.1%	$15K-1.1%	$15K+212.7%	$5K-98.3%	$274K+457340.0%	$60	N/A
Gross Profit	$23K-31.9%	$34K+7040.4%	$473+22.5%	$386+114.7%	-$3K-112.3%	$21K+35475.0%	$60+9.1%	$55
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$5K-37.9%	$8K-39.5%	$12K+83.7%	$7K-81.3%	$36K+530.4%	$6K+97.7%	$3K	N/A
Operating Income	$5K-71.2%	$16K+156.8%	-$28K-13.9%	-$25K+55.3%	-$56K-1021.0%	$6K+149.1%	-$12K	N/A
Interest Expense	$6K+12.2%	$5K+632.2%	$696-99.4%	$108K+2.7%	$105K+12.7%	$93K+449.8%	$17K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$19K-61.9%	$49K+269.8%	-$29K+78.2%	-$133K+17.3%	-$161K-84.1%	-$87K-198.6%	-$29K	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GLUC Balance Sheet

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$33K+115.1%	$15K-65.0%	$44K+72.1%	$26K-87.7%	$208K-11.1%	$234K
Current Assets	$33K+117.8%	$15K-65.5%	$44K+70.9%	$26K+2278.3%	$1K-96.0%	$27K
Cash & Equivalents	$21K+899.6%	$2K-57.8%	$5K+585.1%	$711-33.9%	$1K+1212.2%	$82
Inventory	N/A	$8K	$0-100.0%	$25K	N/A	N/A
Accounts Receivable	$12K+272.2%	$3K	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$529K+31.1%	$403K+24.2%	$325K+45.3%	$223K+20.4%	$185K-55.8%	$420K
Current Liabilities	$529K+31.1%	$403K+24.2%	$325K+45.3%	$223K+20.4%	$185K-55.8%	$420K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$495K-27.8%	-$388K-38.2%	-$281K-41.9%	-$198K-990.8%	$22K+111.9%	-$186K
Retained Earnings	-$6.2M-7.0%	-$5.8M-4.8%	-$5.6M-13.7%	-$4.9M-70.6%	-$2.9M0.0%	-$2.9M

Metric	Q3'17	Q2'17	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15
Total Assets	$26K-3.5%	$27K+44.8%	$19K-43.1%	$33K-24.6%	$44K-78.8%	$207K+301.1%	$52K+235.1%	$15K
Current Assets	$26K-3.5%	$27K+45.4%	$19K-43.4%	$33K-24.6%	$44K-78.9%	$207K+302.9%	$51K+239.8%	$15K
Cash & Equivalents	$17K-9.2%	$18K+103.3%	$9K-56.1%	$21K-13.1%	$24K-14.9%	$28K+1327.2%	$2K-5.3%	$2K
Inventory	$0	$0	$0	N/A	$6K-22.8%	$8K0.0%	$8K-0.7%	$8K
Accounts Receivable	$9K+3.5%	$9K-8.7%	$10K-17.8%	$12K-0.2%	$12K-93.0%	$168K+5244.3%	$3K0.0%	$3K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$453K-5.0%	$477K-12.1%	$542K+2.6%	$529K+26.6%	$418K-1.5%	$424K-6.8%	$455K+12.8%	$403K
Current Liabilities	$453K-5.0%	$477K-12.1%	$542K+2.6%	$529K+26.6%	$418K-1.5%	$424K-6.8%	$455K+12.8%	$403K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$426K+5.1%	-$449K+14.2%	-$524K-5.7%	-$495K-32.6%	-$374K-72.4%	-$217K+46.2%	-$403K-3.9%	-$388K
Retained Earnings	-$6.2M+0.3%	-$6.2M+0.8%	-$6.3M-0.5%	-$6.2M-2.0%	-$6.1M-2.7%	-$6.0M-1.6%	-$5.9M-0.5%	-$5.8M

GLUC Cash Flow Statement

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$39K	N/A	-$135K	N/A	-$84K-259.2%	-$23K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$250+200.0%	-$250	N/A	N/A	N/A	N/A
Financing Cash Flow	$58K	N/A	$140K	N/A	$79K+278.4%	$21K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'17	Q2'17	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15
Operating Cash Flow	-$2K-141.3%	-$695+94.0%	-$12K-244.6%	-$3K-105.4%	$62K+225.8%	-$49K-1.2%	-$49K-426.1%	-$9K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Financing Cash Flow	$0	N/A	N/A	$0+100.0%	-$66K-188.0%	$75K+54.6%	$49K+1840.0%	$3K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GLUC Financial Ratios

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	6.1%-3.2pp	9.3%+766.0pp	-756.7%+176.8pp	-933.5%	N/A	N/A
Operating Margin	-27.7%	N/A	N/A	N/A	N/A	N/A
Net Margin	-131.0%	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	-1797.7%	N/A
Return on Assets	-1238.3%	N/A	N/A	N/A	-192.2%+192.6pp	-384.8%
Current Ratio	0.06+0.0	0.04-0.1	0.13+0.0	0.11+0.1	0.01-0.1	0.06
Debt-to-Equity	-1.07-0.0	-1.04+0.1	-1.16-0.0	-1.13-9.5	8.35+10.6	-2.26
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'17	Q2'17	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15
Gross Margin	96.7%-2.5pp	99.2%+96.1pp	3.1%+0.6pp	2.5%+126.9pp	-124.4%-131.6pp	7.2%-42.8pp	50.0%+46.7pp	3.4%
Operating Margin	19.5%-27.7pp	47.2%+234.6pp	-187.4%-23.8pp	-163.6%+2469.4pp	-2633.0%-2635.0pp	2.0%+10231.2pp	-10229.2%	N/A
Net Margin	78.9%-65.8pp	144.7%+336.7pp	-192.0%+683.6pp	-875.5%+6746.2pp	-7621.8%-7592.2pp	-29.5%+24356.3pp	-24385.8%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	71.2%-109.1pp	180.3%+334.1pp	-153.8%+247.5pp	-401.2%-35.4pp	-365.8%-323.6pp	-42.2%+14.5pp	-56.7%	N/A
Current Ratio	0.060.0	0.06+0.0	0.03-0.0	0.06-0.0	0.10-0.4	0.49+0.4	0.11+0.1	0.04
Debt-to-Equity	-1.060.0	-1.06-0.0	-1.04+0.0	-1.07+0.1	-1.12+0.8	-1.96-0.8	-1.13-0.1	-1.04
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$495K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

THE PLANTING HOPE COMPANY INC MYLKF

$1.3M

Better Moo(d) MOOOF

$1.2M

CULT FOOD SCIENCE CORP CULTF

$1.0M

Oragin Foods Inc OGGFF

$2.3M

Cyanotech CYAN

$3.0M

Frequently Asked Questions

What is Glucose Health Inc's annual revenue?

Glucose Health Inc (GLUC) reported $313K in total revenue for fiscal year 2016. This represents a 7232.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Glucose Health Inc's revenue growing?

Glucose Health Inc (GLUC) revenue grew by 7232.1% year-over-year, from $4K to $313K in fiscal year 2016.

Is Glucose Health Inc profitable?

No, Glucose Health Inc (GLUC) reported a net income of -$410K in fiscal year 2016, with a net profit margin of -131.0%.

What is Glucose Health Inc's gross margin?

Glucose Health Inc (GLUC) had a gross margin of 6.1% in fiscal year 2016, indicating the percentage of revenue retained after direct costs of goods sold.

What is Glucose Health Inc's operating margin?

Glucose Health Inc (GLUC) had an operating margin of -27.7% in fiscal year 2016, reflecting the profitability of core business operations before interest and taxes.

What is Glucose Health Inc's net profit margin?

Glucose Health Inc (GLUC) had a net profit margin of -131.0% in fiscal year 2016, representing the share of revenue converted into profit after all expenses.

What is Glucose Health Inc's operating cash flow?

Glucose Health Inc (GLUC) generated -$39K in operating cash flow during fiscal year 2016, representing cash generated from core business activities.

What are Glucose Health Inc's total assets?

Glucose Health Inc (GLUC) had $33K in total assets as of fiscal year 2016, including both current and long-term assets.

How many shares does Glucose Health Inc have outstanding?

Glucose Health Inc (GLUC) had 3M shares outstanding as of fiscal year 2016.

What is Glucose Health Inc's current ratio?

Glucose Health Inc (GLUC) had a current ratio of 0.06 as of fiscal year 2016, which is below 1.0, which may suggest potential liquidity concerns.

What is Glucose Health Inc's debt-to-equity ratio?

Glucose Health Inc (GLUC) had a debt-to-equity ratio of -1.07 as of fiscal year 2016, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Glucose Health Inc's return on assets (ROA)?

Glucose Health Inc (GLUC) had a return on assets of -1238.3% for fiscal year 2016, measuring how efficiently the company uses its assets to generate profit.

What is Glucose Health Inc's cash runway?

Based on fiscal year 2016 data, Glucose Health Inc (GLUC) had $21K in cash against an annual operating cash burn of $39K. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Glucose Health Inc's debt-to-equity ratio negative or unusual?

Glucose Health Inc (GLUC) has negative shareholder equity of -$495K as of fiscal year 2016, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Glucose Health Inc's Altman Z-Score?

Glucose Health Inc (GLUC) has an Altman Z-Score of -269.78, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Glucose Health Inc's Piotroski F-Score?

Glucose Health Inc (GLUC) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Glucose Health Inc's earnings high quality?

Glucose Health Inc (GLUC) has an earnings quality ratio of 0.10x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Glucose Health Inc cover its interest payments?

Glucose Health Inc (GLUC) has an interest coverage ratio of -0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.